FDA Inspection 1051599 — Oklahoma Blood Institute
The FDA completed an inspection of Oklahoma Blood Institute on Apr 4, 2018 in Fort Smith, AR. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 4, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Fort Smith, AR (United States)